TY - JOUR
T1 - Direct activation of a bacterial innate immune system by a viral capsid protein
AU - Zhang, Tong
AU - Tamman, Hedvig
AU - Coppieters ’t Wallant, Kyo
AU - Kurata, Tatsuaki
AU - LeRoux, Michele
AU - Srikant, Sriram
AU - Brodiazhenko, Tetiana
AU - Cepauskas, Albinas
AU - Talavera, Ariel
AU - Martens, Chloe
AU - Atkinson, Gemma C.
AU - Hauryliuk, Vasili
AU - Garcia-Pino, Abel
AU - Laub, Michael T.
N1 - Funding Information:
We thank A. Harms for sharing the BASEL phage collection; the MIT BioMicro Center and its staff for their support in sequencing; the MIT Biopolymers and Proteomics Core and its staff for their help in mass spectrometry experiments; W. Verseés for allowing the use of the biophysics facilities at the VUB; the Mass Spectrometry Laboratory at ULiège and Thomas Tilmant for support and assistance regarding MS data acquisition; K. Gozzi and B. Wang for comments on the manuscript; and all members of the Laub laboratory for helpful discussions. G.C.A. and V.H. were supported by the Swedish Research council (grant 2018-00956 within the RIBOTARGET consortium under the framework of JPIAMR, project grants 2017-03783 and 2021-01146 to V.H., project grant 2019-01085 to G.C.A.), the Knut and Alice Wallenberg Foundation (2020.0037 to G.C.A.), the Ragnar Söderberg Foundation (M23/14 to V.H.), the European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology (V.H.), and the Estonian Science Foundation (project grant PRG335 to V.H.). A.G.-P. was supported by Fonds National de Recherche Scientifique (FRFS-WELBIO CR-2017S-03, FNRS CDR J.0068.19, FNRS-EQP UN.025.19 and FNRS-PDR T.0090.22), the European Research Council (CoG DiStRes, no. 864311), the Joint Programming Initiative on Antimicrobial Resistance (JPI-EC-AMR-R.8004.18), the Programme Actions de Recherche Concerté 2016-2021, Fonds Jean Brachet and the Fondation Van Buuren, Chargé de Recherches fellowship from the FNRS no. CR/DM-392 (H.T.). A.C. and K.C.W. are fellows of the FRIA, C.M. is supported as a Research Associate of the FRS–FNRS. C.M. was supported by grant F.4532.22 from the FRS–FNRS. The authors acknowledge the use of the PROXIMA 1 and 2A beamlines at the Soleil synchrotron (Gif-sur-Yvette, France). M.T.L. is an Investigator of the Howard Hughes Medical Institute.
Funding Information:
We thank A. Harms for sharing the BASEL phage collection; the MIT BioMicro Center and its staff for their support in sequencing; the MIT Biopolymers and Proteomics Core and its staff for their help in mass spectrometry experiments; W. Verseés for allowing the use of the biophysics facilities at the VUB; the Mass Spectrometry Laboratory at ULiège and Thomas Tilmant for support and assistance regarding MS data acquisition; K. Gozzi and B. Wang for comments on the manuscript; and all members of the Laub laboratory for helpful discussions. G.C.A. and V.H. were supported by the Swedish Research council (grant 2018-00956 within the RIBOTARGET consortium under the framework of JPIAMR, project grants 2017-03783 and 2021-01146 to V.H., project grant 2019-01085 to G.C.A.), the Knut and Alice Wallenberg Foundation (2020.0037 to G.C.A.), the Ragnar Söderberg Foundation (M23/14 to V.H.), the European Regional Development Fund through the Centre of Excellence for Molecular Cell Technology (V.H.), and the Estonian Science Foundation (project grant PRG335 to V.H.). A.G.-P. was supported by Fonds National de Recherche Scientifique (FRFS-WELBIO CR-2017S-03, FNRS CDR J.0068.19, FNRS-EQP UN.025.19 and FNRS-PDR T.0090.22), the European Research Council (CoG DiStRes, no. 864311), the Joint Programming Initiative on Antimicrobial Resistance (JPI-EC-AMR-R.8004.18), the Programme Actions de Recherche Concerté 2016-2021, Fonds Jean Brachet and the Fondation Van Buuren, Chargé de Recherches fellowship from the FNRS no. CR/DM-392 (H.T.). A.C. and K.C.W. are fellows of the FRIA, C.M. is supported as a Research Associate of the FRS–FNRS. C.M. was supported by grant F.4532.22 from the FRS–FNRS. The authors acknowledge the use of the PROXIMA 1 and 2A beamlines at the Soleil synchrotron (Gif-sur-Yvette, France). M.T.L. is an Investigator of the Howard Hughes Medical Institute.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/12/1
Y1 - 2022/12/1
N2 - Bacteria have evolved diverse immunity mechanisms to protect themselves against the constant onslaught of bacteriophages1–3. Similar to how eukaryotic innate immune systems sense foreign invaders through pathogen-associated molecular patterns4 (PAMPs), many bacterial immune systems that respond to bacteriophage infection require phage-specific triggers to be activated. However, the identities of such triggers and the sensing mechanisms remain largely unknown. Here we identify and investigate the anti-phage function of CapRelSJ46, a fused toxin–antitoxin system that protects Escherichia coli against diverse phages. Using genetic, biochemical and structural analyses, we demonstrate that the C-terminal domain of CapRelSJ46 regulates the toxic N-terminal region, serving as both antitoxin and phage infection sensor. Following infection by certain phages, newly synthesized major capsid protein binds directly to the C-terminal domain of CapRelSJ46 to relieve autoinhibition, enabling the toxin domain to pyrophosphorylate tRNAs, which blocks translation to restrict viral infection. Collectively, our results reveal the molecular mechanism by which a bacterial immune system directly senses a conserved, essential component of phages, suggesting a PAMP-like sensing model for toxin–antitoxin-mediated innate immunity in bacteria. We provide evidence that CapRels and their phage-encoded triggers are engaged in a ‘Red Queen conflict’5, revealing a new front in the intense coevolutionary battle between phages and bacteria. Given that capsid proteins of some eukaryotic viruses are known to stimulate innate immune signalling in mammalian hosts6–10, our results reveal a deeply conserved facet of immunity.
AB - Bacteria have evolved diverse immunity mechanisms to protect themselves against the constant onslaught of bacteriophages1–3. Similar to how eukaryotic innate immune systems sense foreign invaders through pathogen-associated molecular patterns4 (PAMPs), many bacterial immune systems that respond to bacteriophage infection require phage-specific triggers to be activated. However, the identities of such triggers and the sensing mechanisms remain largely unknown. Here we identify and investigate the anti-phage function of CapRelSJ46, a fused toxin–antitoxin system that protects Escherichia coli against diverse phages. Using genetic, biochemical and structural analyses, we demonstrate that the C-terminal domain of CapRelSJ46 regulates the toxic N-terminal region, serving as both antitoxin and phage infection sensor. Following infection by certain phages, newly synthesized major capsid protein binds directly to the C-terminal domain of CapRelSJ46 to relieve autoinhibition, enabling the toxin domain to pyrophosphorylate tRNAs, which blocks translation to restrict viral infection. Collectively, our results reveal the molecular mechanism by which a bacterial immune system directly senses a conserved, essential component of phages, suggesting a PAMP-like sensing model for toxin–antitoxin-mediated innate immunity in bacteria. We provide evidence that CapRels and their phage-encoded triggers are engaged in a ‘Red Queen conflict’5, revealing a new front in the intense coevolutionary battle between phages and bacteria. Given that capsid proteins of some eukaryotic viruses are known to stimulate innate immune signalling in mammalian hosts6–10, our results reveal a deeply conserved facet of immunity.
UR - http://www.scopus.com/inward/record.url?scp=85141941741&partnerID=8YFLogxK
U2 - 10.1038/s41586-022-05444-z
DO - 10.1038/s41586-022-05444-z
M3 - Article
C2 - 36385533
AN - SCOPUS:85141941741
SN - 0028-0836
VL - 612
SP - 132
EP - 140
JO - Nature
JF - Nature
IS - 7938
ER -